Table: Towa Pharmaceutical -2018/19 parent results

TOWA PHARMACEUTICAL

14/05/2019 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            102.43           90.99                                
                 (+12.6 pct)     (+10.0 pct)                             
  Operating         15.80           12.11                                
                 (+30.5 pct)     (+55.8 pct)                             
  Recurring         18.97            8.83                                
                (+115.0 pct)     (+5.6 pct)                              
  Net               13.61            5.48                                
                (+148.4 pct)     (-17.7 pct)                             
  EPS            276.62 yen      111.36 yen                              
  EPS Diluted    255.88 yen      102.93 yen                              
  Ann Div        107.50 yen       95.00 yen      44.00 yen               
  -Q2 Div         47.50 yen       47.50 yen      22.00 yen               
  -Q4 Div         60.00 yen       47.50 yen      22.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T